Trimetazidine in the prevention of contrast‐induced nephropathy after coronary procedures

OBJECTIVE: To evaluate the efficacy of trimetazidine (TMZ) in the prevention of contrast‐induced nephropathy (CIN) in patients with high serum creatinine levels undergoing coronary angiography/angioplasty. METHODS: TMZ (20 mg thrice daily) was administered orally for 72 h starting 48 h before the pr...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Onbasili, Alper O, Yeniceriglu, Yavuz, Agaoglu, Pınar, Karul, Aslıhan, Tekten, Tarkan, Akar, Harun, Discigil, Guzel
Format: Artigo
Jezik:Inglês
Izdano: BMJ Group 2007
Teme:
Interventional Cardiology
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1955192/
https://ncbi.nlm.nih.gov/pubmed/17065180
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/hrt.2006.097477
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items